Novel models for defining function of the BAFF/APRIL cytokine family
Novel models for defining function of the BAFF/APRIL cytokine family
批准号:
8787449
负责人:
Anne Davidson
金额:
$8.43万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2016-12-31
关键词:
Animal ModelAntibodiesAutoimmune DiseasesAutoimmunityB cell differentiationB-LymphocytesBindingBiological Response Modifier TherapyBiologyBone MarrowCell SurvivalCell surfaceCellsClinicalDevelopmentDisadvantagedDiseaseDrug TargetingDsRedEvaluationFamilyFlow CytometryFundingGoalsHealthHomeostasisHomologous GeneHumanImmune responseImmune systemImmunoglobulin AImmunoglobulin Class SwitchingInflammationLaboratoriesLearningLupusMalignant NeoplasmsMediator of activation proteinMethodsModelingMusPatientsPhase III Clinical TrialsPlasma CellsRelative (related person)ReporterRestRoleScientistSerumSourceStagingSumSystemic Lupus ErythematosusTNF geneTestingautoreactive B cellbelimumabcell typecytokinedesigndrug developmenthuman ANP32B proteinimmune activationimmune functioninsightinterestlupus-likeneonatenoveloverexpressionprogramsreceptorresearch studyresponsetherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): BAFF and its homolog APRIL are TNF-like cytokines that support the survival and differentiation of B cells. BAFF binds to three receptors, BAFF-R, TACI, and BCMA that are expressed on B cells at different developmental stages, whereas APRIL binds only to TACI and BCMA. Overexpression of BAFF causes a lupus-like illness in animal models and high levels of BAFF are found in several autoimmune diseases. Therefore the BAFF/APRIL family has been a target of extensive drug development over the last decade, culminating in the approval in 2011 of the anti-BAFF antibody belimumab for the treatment of lupus. Although much has been learned about this family of cytokines over the last decade, important questions remain about the mechanism of action of BAFF inhibition, the precise role of APRIL and the relative role of each of the three receptors, especially TACI. The experiments proposed here are designed to give us tools that will yield new insights into the basic biology of BAFF and APRIL and their receptors and thereby suggest ways in which therapeutic targeting of these cytokines may be most beneficial for patients. We will therefore generate two new models, an APRIL reporter mouse that allows us to visualize where APRIL protein is being made and a conditionally deficient TACI mouse that allows us to determine the role of TACI on specific cell types. These mice, together with tools we already have, will allow us to better defin the microenvironments in which BAFF and APRIL are expressed during homeostasis and during immune activation, and to better understand the relative importance of TACI in regulating B cell responses.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Dissecting the heterogeneity and function of myeloid cells in lupus nephritis
-
批准号:10588862
-
项目类别:
-
资助金额:$61.82万
-
财政年份:2023
-
负责人:Anne Davidson
-
依托单位:
Etiology and outcome of MIS-C (PRISM)
-
批准号:10382573
-
项目类别:
-
资助金额:$68.41万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
T32 Training Grant in Translational Immunology
-
批准号:10470893
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
-
批准号:10301657
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
T32 Training Grant in Translational Immunology
-
批准号:10653079
-
项目类别:
-
资助金额:$27.69万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
-
批准号:10434117
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
Induction of lupus-related autoantibodies by TNF inhibitors
-
批准号:10405223
-
项目类别:
-
资助金额:$68.41万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
T32 Training Grant in Translational Immunology
-
批准号:10269999
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2021
-
负责人:Anne Davidson
-
依托单位:
Etiology and outcome of MIS-C
-
批准号:10198501
-
项目类别:
-
资助金额:$149.19万
-
财政年份:2020
-
负责人:Anne Davidson
-
依托单位:
Project-003
-
批准号:10394464
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
-
批准号:10159859
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
-
批准号:9903204
-
项目类别:
-
资助金额:$44.67万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
-
批准号:10397086
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Project-003
-
批准号:10397089
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Project-003
-
批准号:10617663
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2019
-
负责人:Anne Davidson
-
依托单位:
Belimumab for Maintenance Therapy in Idiopathic Inflammatory Myositis
-
批准号:9320115
-
项目类别:
-
资助金额:$18.15万
-
财政年份:2017
-
负责人:Anne Davidson
-
依托单位:
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
-
批准号:8693192
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2014
-
负责人:Anne Davidson
-
依托单位:
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
-
批准号:9064068
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2014
-
负责人:Anne Davidson
-
依托单位:
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
-
批准号:9293247
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2014
-
负责人:Anne Davidson
-
依托单位:
Regulation of the anti-phospholipid response in SLE
-
批准号:8666335
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2010
-
负责人:Anne Davidson
-
依托单位:
海外基金